Liver Transplantation

• 

  Subject Areas on Research

  • "Too Female" for Liver Transplantation. 
  • 100 consecutive liver transplants in infants and children: an 8-year experience. 
  • 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. 
  • A 29-year-old woman with sudden anemia and arterial oxygen desaturation. 
  • A Comprehensive Review of Outcome Predictors in Low MELD Patients. 
  • A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. 
  • A Propensity-matched Survival Analysis: Do Simultaneous Liver-lung Transplant Recipients Need a Liver? 
  • A Question Seeking for an Answer: Use of T-tube in the Era of Liver Transplantation With Grafts From Extended Criteria Donors and Donors After Cardiac Death. 
  • A UNOS perspective on donor liver allocation. United Network for Organ Sharing. 
  • A case of electrical storm in a liver transplant patient. 
  • A comparison of operation, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography in biliary complications after hepatic transplantation. 
  • A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. 
  • A long-term experience with expansion of Milan criteria for liver transplant recipients. 
  • A meta-analysis of complications following deceased donor liver transplant. 
  • A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. 
  • A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. 
  • A new technique for combined liver/small intestinal transplantation. 
  • A synergistic effect of total lymphoid irradiation, cyclosporine, and splenectomy in a hamster-to-rat hepatic xenograft model. 
  • A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. 
  • AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma. 
  • Abdominal complications in organ transplant recipients. 
  • Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and mycophenolate mofetil in a liver transplant patient: a case report and review of the literature. 
  • Acute Budd-Chiari syndrome during pregnancy: surgical treatment and orthotopic liver transplantation with successful completion of the pregnancy. 
  • Acute Hepatic Failure and Nutrition. 
  • Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens. 
  • Acute pancreatitis and fulminant hepatic failure. 
  • Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. 
  • Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients. 
  • Adenovirus infections in pediatric small bowel transplant recipients. 
  • Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic. 
  • Allocation of transplantable organs: do people want to punish patients for causing their illness? 
  • Alterations in intrahepatic hemodynamics of the harvested porcine liver. 
  • An appraisal of technical variant grafts compared to whole liver grafts in pediatric liver transplant recipients: Multicenter analysis from the SPLIT registry. 
  • An examination of factors predicting prioritization for liver transplantation. 
  • Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. 
  • Aneurysms in abdominal organ transplant recipients. 
  • Annual literature review for clinical transplants 2005. 
  • Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation. 
  • Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. 
  • Apoptosis and hepatic allograft reperfusion injury. 
  • Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. 
  • Applying the WHO conceptual framework for the International Classification for Patient Safety to a surgical population. 
  • Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis. 
  • Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass Index. 
  • Association between anesthesiologist experience and mortality after orthotopic liver transplantation. 
  • Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. 
  • Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. 
  • Association of the Affordable Care Act on Access to and Outcomes After Kidney or Liver Transplant: A Transplant Registry Study. 
  • Basiliximab decreases the incidence of acute rejection after intestinal transplantation. 
  • Belatacept: is there BENEFIT for liver transplantation too? 
  • Benefit of social media on patient engagement and satisfaction: Results of a 9-month, qualitative pilot study using Facebook. 
  • Beyond death and graft survival-Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. 
  • Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation. 
  • Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list. 
  • Bile acids in xenogeneic ex-vivo liver perfusion: function of xenoperfused livers and compatibility with human bile salts and porcine livers. 
  • Bile compositional changes and cholesterol stone formation following orthotopic liver transplantation. 
  • Biliary atresia-polysplenia syndrome: surgical and clinical relevance in liver transplantation. 
  • Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. 
  • Biliary response to glucagon and insulin following hepatic transplantation in humans. 
  • Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation. 
  • Biliary tract complications after orthotopic liver transplantation. 
  • Bleeding Complications from Transesophageal Echocardiography for Liver Transplantation: A Systematic Review. 
  • Bleeding and thrombotic complications of pediatric liver transplant. 
  • Blood Pressure Variability Early After Liver Transplantation Predicts Long-Term Mortality. 
  • Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury. 
  • Bradycardia in children less than two years of age during liver transplantation. 
  • Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma. 
  • Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. 
  • Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. 
  • Burden of early hospitalization after simultaneous liver-kidney transplantation: Results from the US Multicenter SLKT Consortium. 
  • Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study. 
  • COVID-19 Among Liver Transplant Recipients. 
  • COVID-19 and Liver Transplantation: Early Reports and Recommendations. 
  • CT and MR imaging evaluation of living liver donors. 
  • Campath-1H in intestinal and multivisceral transplantation: preliminary data. 
  • Cardiac Events Within the 30-Day Postoperative Period Is Associated With Increased 1-Year Mortality Among Deceased-Donor Liver Transplant Recipients. 
  • Case 23-2005: a man with a mass in the liver. 
  • Catatonia After Liver Transplantation. 
  • Causes of late mortality in pediatric liver transplant recipients. 
  • Causes of late mortality in pediatric liver transplant recipients. 
  • Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation. 
  • Changes in frailty are associated with waitlist mortality in patients with cirrhosis. 
  • Characteristics of alloreactive rat T cell lines established from low and high rejecting orthotopic liver transplants. 
  • Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study. 
  • Chronic abdominal pain in a liver transplant recipient. 
  • Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. 
  • Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success. 
  • Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction. 
  • Class II alloantibody and mortality in simultaneous liver-kidney transplantation. 
  • Clonal contributions of small numbers of retrovirally marked hematopoietic stem cells engrafted in unirradiated neonatal W/Wv mice. 
  • Clostridial infection of a liver transplant treated with retransplantation. 
  • Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973. 
  • Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. 
  • Combined lung-liver-pancreas transplantation in a recipient with cystic fibrosis. 
  • Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis. 
  • Complications of total hip arthroplasty following solid organ transplantation. 
  • Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. 
  • Continuing evolution in the approach to severe liver trauma. 
  • Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. 
  • Controlled non-heart-beating donors: a potential source of extrarenal organs. 
  • Coronary artery disease and liver transplantation: the state of the art. 
  • Correction of severe combined immunodeficiency by fetal liver cells. 
  • Cost of achieving equivalent outcomes in sicker patients after liver transplant. 
  • Critical Care and Mechanical Ventilation Practices Surrounding Liver Transplantation in Children: A Multicenter Collaborative. 
  • Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes. 
  • Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination. 
  • Current Approaches in the Management of Hepatic Adenomas. 
  • Current management of esophageal variceal bleeding. 
  • Current management of sinusoidal portal hypertension. 
  • Cytomegalovirus infection following liver transplantation: review of the literature. 
  • Damage-Associated Molecular Patterns Induce Inflammatory Injury During Machine Preservation of the Liver: Potential Targets to Enhance a Promising Technology. 
  • Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. 
  • De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation. 
  • De novo nonalcoholic fatty liver disease after liver transplantation. 
  • De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant. 
  • Death and liver transplantation within 2 years of onset of drug-induced liver injury. 
  • Death of a living liver donor from illicit drugs. 
  • Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes. 
  • Declined organ offers in liver transplantation: careful timing or missed opportunity? 
  • Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy. 
  • Defining long-term outcomes with living donor liver transplantation in North America. 
  • Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience. 
  • Depression in primary caregivers of patients listed for liver or kidney transplantation. 
  • Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows. 
  • Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows. 
  • Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows. 
  • Diaphragmatic Hernias after Living Donor Hepatectomy: A Critical Reappraisal. 
  • Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. 
  • Differential effects of donor-specific alloantibody. 
  • Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat model. 
  • Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. 
  • Discussion. 
  • Disparities in liver transplantation before and after introduction of the MELD score. 
  • Disseminated Adenovirus Infection After Combined Liver-Kidney Transplantation. 
  • Disseminated Legionella micdadei infection in a liver transplant patient presenting as pulmonary nodules and a laryngeal lesion. 
  • Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient. 
  • Distinctive clinical features of portopulmonary hypertension. 
  • Distributing scarce livers: the moral reasoning of the general public. 
  • Dobutamine stress echocardiography for orthotopic liver transplant evaluation. 
  • Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. 
  • Domino liver transplantation in maple syrup urine disease: a case report and review of the literature. 
  • Donation after cardiac death: the University of Wisconsin experience with liver transplantation. 
  • Donation after cardiac death: the University of Wisconsin experience. 
  • Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index. 
  • Donor hepatic function: a factor in postreperfusion syndrome. 
  • Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. 
  • Donor risk index predicts graft failure reliably but not post-transplant infections. 
  • Donor-Recipient Height Mismatch Is Associated With Decreased Survival in Pediatric-to-Adult Liver Transplant Recipients. 
  • Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. 
  • Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. 
  • Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. 
  • Duct of Luschka Bile Leak Following Deceased Donor Liver Transplant. 
  • Early Postoperative Emergency Department Care of Abdominal Transplant Recipients. 
  • Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective. 
  • Early versus delayed initiation of cytomegalovirus prophylaxis after liver transplant. 
  • Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. 
  • Effect of cyclosporine on renal function in survivors of liver transplantation after 1 year. 
  • Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. 
  • Effect of hepatic artery flow on bile secretory function after cold ischemia. 
  • Effect of orthotopic liver transplantation on employment and health status. 
  • Effect of postoperative complications on health and employment following liver transplantation. 
  • Effect of surgical and spontaneous portasystemic shunts on liver transplantation. 
  • Effectiveness of Transarterial Embolization of Hepatocellular Carcinoma as a Bridge to Transplantation. 
  • Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts. 
  • Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management. 
  • Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study. 
  • Electroconvulsive therapy for severe major depressive disorder after orthotopic liver transplantation. 
  • Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival. 
  • Emergencies after liver transplantation. 
  • Ensuring long-term equity after pediatric liver transplantation. 
  • Equalizing MELD Scores Over Broad Geographies Is Not the Most Efficacious Way to Allocate a Scarce Resource in a Value-based Environment. 
  • Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health. 
  • Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. 
  • Evaluation of an Abnormal Liver Panel After Liver Transplantation. 
  • Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. 
  • Evaluation of selective liver denervation methods. 
  • Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. 
  • Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. 
  • Ex-vivo liver perfusion for organ preservation: Recent advances in the field. 
  • Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation. 
  • Experience with combined hepatic, pancreaticoduodenal, and renal procurement with UW solution. 
  • Experience with enteric conversion after pancreas transplantation with bladder drainage. 
  • Experience with pancreas retransplantation. 
  • Experience with reduced-size liver transplantation in infants and children. 
  • Extending the boundaries of acceptable organ donors: a means of expanding the donor pool for liver transplantation. 
  • Extracorporeal liver perfusion using human and pig livers for acute liver failure. 
  • FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients. 
  • Factors associated with cardiovascular events after simultaneous liver-kidney transplant from the US Multicenter Simultaneous Liver-Kidney Transplant Consortium. 
  • Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient? 
  • Finding a place for public preferences in liver allocation decisions. 
  • Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. 
  • Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. 
  • Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. 
  • Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era. 
  • From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. 
  • Fully covered self-expandable metallic stents in the management of complex biliary leaks: preliminary data - a case series. 
  • Fulminant hepatic failure from the Budd-Chiari syndrome. A bridge to transplantation with transjugular intrahepatic portosystemic shunt. 
  • Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. 
  • Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus. 
  • Gender Disparities in Patients With Alcoholic Liver Disease Evaluated for Liver Transplantation. 
  • Generation of bone marrow and fetal liver chimeric mice. 
  • Geographic favoritism in liver transplantation--unfortunate or unfair? 
  • Geographic favoritism in liver transplantation. 
  • Getting a "Grip" on Sarcopenia for the Liver Transplant Candidate: Time to Focus on Muscle Function. 
  • Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma. 
  • Going the distance for procurement of donation after circulatory death livers for transplantation-Does reimbursement reflect reality? 
  • Guidance for liver transplant immunosuppression. 
  • HLA-B*35:01 and Green Tea-Induced Liver Injury. 
  • HLA-C and liver transplant outcomes: interpreting the facts. 
  • HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV. 
  • Hemodynamic and Clinical Determinants of Left Atrial Enlargement in Liver Transplant Candidates. 
  • Hemodynamic and metabolic variables predict porcine ex vivo liver function. 
  • Hepatic allograft-derived Kupffer cells regulate T cell response in rats. 
  • Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection. 
  • Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. 
  • Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. 
  • Hepatitis C. 
  • Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma. 
  • Hepatocellular carcinoma and model for end-stage liver disease exceptions: the more we understand, the more challenging the allocation gets. 
  • Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. 
  • Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements. 
  • Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. 
  • High clinical suspicion of donor-derived disease leads to timely recognition and early intervention to treat solid organ transplant-transmitted lymphocytic choriomeningitis virus. 
  • Hilar cholangiocarcinoma. 
  • Histocompatibility and liver transplantation. 
  • Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. 
  • Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class I antigens in vitro: I. Specificity for polymorphic domains. 
  • Humoral rejection of rat hepatic transplants by passive transfer of serum. 
  • Hyperacute rejection of liver transplants in rats. 
  • Identification of poorly performing transplant centers using the UNOS center-specific data. 
  • Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. 
  • Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. 
  • IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients. 
  • Illness Uncertainty in Patients Awaiting Liver Transplant. 
  • Imaging in the preoperative evaluation of adult liver-transplant candidates: goals, merits of various procedures, and recommendations. 
  • Immunoregulation and tolerance. 
  • Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus. 
  • Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients. 
  • Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. 
  • Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. 
  • Impact of donor factors and preservation on function and survival after liver transplantation. 
  • Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). 
  • Impact of psychosocial factors on medication level variability index and outcomes in pediatric liver transplant recipients. 
  • Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. 
  • Impaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients. 
  • Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. 
  • Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma. 
  • Improved survival in simultaneous lung-liver recipients and candidates in the modern era of lung allocation. 
  • Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis. 
  • Improvement in survival associated with adult-to-adult living donor liver transplantation. 
  • In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection. 
  • In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. 
  • Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. 
  • Incidence and risk factors of incisional hernia formation following abdominal organ transplantation. 
  • Incidence of Postreperfusion Hyperfibrinolysis in Liver Transplantation by Donor Type and Observed Treatment Strategies. 
  • Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? 
  • Indications and techniques for renal, pancreas, and liver transplantation. 
  • Induction immunosuppression in liver transplantation: a review. 
  • Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. 
  • Infant pediatric liver transplantation results equal those for older pediatric patients. 
  • Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. 
  • Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. 
  • Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance. 
  • Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. 
  • Inflammatory bowel disease following solid organ transplantation. 
  • Influence of donor base deficit status on recipient outcomes in liver transplantation. 
  • Inter-relations between 3-hydroxypropionate and propionate metabolism in rat liver: relevance to disorders of propionyl-CoA metabolism. 
  • Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. 
  • Intestinal transplantation: a single-center experience. 
  • Intestinal transplantation: the University of Wisconsin experience. 
  • Intracardiac thrombus formation during orthotopic liver transplantation: a new entity or an old enemy? 
  • Intraoperative Versus Extended Antibiotic Prophylaxis in Liver Transplant Surgery: A Randomized Controlled Pilot Trial. 
  • Intraoperative fluid management during orthotopic liver transplantation. 
  • Intraoperative vasoplegia: methylene blue to the rescue! 
  • Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function. 
  • Is the HCV pipeline heading in the right direction? 
  • Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. 
  • Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. 
  • Isolated liver transplantation in infants with total parenteral nutrition-associated end-stage liver disease. 
  • Kinetics of hepatitis C virus reinfection after liver transplantation. 
  • Kupffer cells: another player in liver tolerance induction. 
  • Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. 
  • Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. 
  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. 
  • Left lateral segment liver volume is not correlated with anthropometric measures. 
  • Life-long bleeding diathesis: effect of orthotopic liver transplantation. 
  • Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation. 
  • Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence. 
  • Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. 
  • Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study. 
  • Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates. 
  • Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. 
  • Liver Transplantation in 2016: An Update. 
  • Liver and intestine transplantation in the United States 1998-2007. 
  • Liver and intestine transplantation in the United States, 1997-2006. 
  • Liver and small bowel transplantation: therapeutic alternatives for the treatment of liver disease and intestinal failure. 
  • Liver disease in pregnancy. 
  • Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. 
  • Liver retransplantation: the University of Wisconsin experience. 
  • Liver transplant biopsies with a biopsy gun. 
  • Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades. 
  • Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. 
  • Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. 
  • Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomes. 
  • Liver transplantation at the University of Wisconsin. 
  • Liver transplantation complicated by misplaced TIPS in the portal vein. 
  • Liver transplantation for HELLP syndrome. 
  • Liver transplantation for alcoholic liver disease. 
  • Liver transplantation for alcoholic liver disease. 
  • Liver transplantation for biliary atresia: 19-year, single-center experience. 
  • Liver transplantation for glycogen storage disease type Ia. 
  • Liver transplantation for glycogen storage disease types I, III, and IV. 
  • Liver transplantation for hepatocellular carcinoma: Management after the transplant. 
  • Liver transplantation for hilar cholangiocarcinoma: A systematic review. 
  • Liver transplantation for liver malignancies in Wilson's disease: two novel cases. 
  • Liver transplantation for pediatric metabolic disease. 
  • Liver transplantation for the treatment of hepatocellular carcinoma. 
  • Liver transplantation for unresectable colorectal liver metastases. 
  • Liver transplantation for unresectable colorectal liver metastases: A systematic review. 
  • Liver transplantation from a cadaver donor with ethylene-glycol-induced brain death. 
  • Liver transplantation from controlled non-heart-beating donors. 
  • Liver transplantation in a patient with primary sclerosing cholangitis suffering from lipomatous pseudohypertrophy of the pancreas. 
  • Liver transplantation in alcoholics: assessment of psychological health and work activity. 
  • Liver transplantation in an adolescent with acute liver failure from acute lymphoblastic leukemia. 
  • Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. 
  • Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin. 
  • Liver transplantation. 
  • Liver transplantation. Initiation of the first program in North Carolina. 
  • Liver: detecting alcohol intake in patients with ALD. 
  • Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors. 
  • Living and deceased donor liver transplantation for unresectable hepatoblastoma at a single center. 
  • Living donor liver transplantation. 
  • Living donor liver transplantation: the historical and cultural basis of policy decisions and ongoing ethical questions. 
  • Living related donor liver transplantation at the University of Nebraska Medical Center (1996). 
  • Living related versus deceased donor liver transplantation for maple syrup urine disease. 
  • Local access to subspecialty care influences the chance of receiving a liver transplant. 
  • Loneliness in adults awaiting liver transplantation at 7 U.S. transplant centers. 
  • Long-term follow-up of auxiliary liver transplantation for fulminant hepatic failure. 
  • Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure. 
  • Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. 
  • Long-term management of the liver transplant patient: recommendations for the primary care doctor. 
  • Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. 
  • Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL). 
  • Long-term results of intestinal transplantation for pseudo-obstruction in children. 
  • Long-term results of liver transplantation for biliary atresia. 
  • Long-term results of liver transplantation in older patients 60 years of age and older. 
  • Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin. 
  • Low volume is associated with worse patient outcomes for pediatric liver transplant centers. 
  • Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients. 
  • MRI in hemiballismus due to subthalamic nucleus hemorrhage: an unusual complication of liver transplantation. 
  • Macrophage migration into hepatic xenografts in the hamster-to-rat combination. 
  • Macroporous Dual-compartment Hydrogels for Minimally Invasive Transplantation of Primary Human Hepatocytes. 
  • Magnetic resonance imaging and hepatic hemodynamics: correlation with metabolic function in liver transplantation candidates. 
  • Magnetic resonance imaging-derived parameter of portal flow predicts volume-mediated pulmonary hypertension in liver transplantation candidates. 
  • Making the Case for Reproductive Counseling in Liver Transplant Care. 
  • Malfunction of the liver after transplantation: an analysis of potential risk factors. 
  • Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. 
  • Measuring the Toll of Acute Illness-Derived Frailty in Decompensated Cirrhosis. 
  • Mechanisms of liver-induced tolerance. 
  • Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. 
  • Mediation of hyperacute rejection of rat hepatic allografts by RT-1 antigens. 
  • Medical problems occurring after orthotopic liver transplantation. 
  • Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. 
  • Methylphenidate-induced autoimmune hepatitis. 
  • Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. 
  • Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. 
  • Monoclonal immunoglobulin-secreting lymphoma in a patient with severe combined immunodeficiency disease. 
  • More than a few good women: honoring the ladies of the liver. 
  • Multi-disciplinary approach to perioperative risk assessment and post-transplant management for liver transplantation in a patient at risk for Brugada syndrome. 
  • Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose? 
  • NFkappaB expression during cold ischemia correlates with postreperfusion graft function. 
  • National survey of adult transplant hepatologists on the pediatric-to-adult care transition after liver transplantation. 
  • Neonatal W-mutant mice are favorable hosts for tracking development of marked hematopoietic stem cells. 
  • Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation. 
  • Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. 
  • Noninvasive markers in the assessment and management of autoimmune liver diseases. 
  • Normothermic and subnormothermic ex-vivo liver perfusion in liver transplantation. 
  • Nutritional outcome and growth of children after intestinal transplantation. 
  • Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. 
  • Omeprozole therapy in pediatric patients after liver and intestinal transplantation. 
  • One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy. 
  • One thousand liver transplants. The lessons learned. 
  • Operating room to intensive care unit handoffs and the risks of patient harm. 
  • Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation. 
  • Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs. 
  • Organ Allocation and Distribution: Lessons to Be Learned and Principles to Lead Us Forward. 
  • Organ allocation for transplantation in the USA and Korea: the changing roles of equity and utility. 
  • Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. 
  • Orthotopic liver transplant patients require less postoperative morphine than do patients undergoing hepatic resection. 
  • Orthotopic liver transplantation for familial amyloidotic polyneuropathy: a pathological study. 
  • Orthotopic liver transplantation in patients 60 years of age and older. 
  • Orthotopic liver transplantation in patients over 60 years of age. 
  • Orthotopic liver transplantation with selective use of venovenous bypass. 
  • Outcome of extra-anatomic vascular reconstruction in orthotopic liver transplantation. 
  • Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium. 
  • Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. 
  • Outcomes of liver retransplantation in patients with primary sclerosing cholangitis. 
  • Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. 
  • Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. 
  • Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. 
  • Overcoming barriers to care for hepatitis C. 
  • Pancreas transplantation: the Nebraska experience. 
  • Patent foramen ovale and intracardiac thrombus identified by transesophageal echocardiography during liver transplantation. 
  • Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. 
  • Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation. 
  • Patterns of Use in Transesophageal Echocardiography for Liver Transplantation: A Systematic Review. 
  • Percutaneous Management of Benign Biliary Strictures with Large-Bore Catheters: Comparison between Patients with and without Orthotopic Liver Transplantation. 
  • Percutaneous transhepatic endoscopic electrohydraulic lithotripsy of biliary tract calculi after orthotopic liver transplantation. 
  • Perioperative Challenges in Liver Transplantation for a Patient With Acute Intermittent Porphyria. 
  • Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation. 
  • Perioperative estimation of the intracranial pressure using the optic nerve sheath diameter during liver transplantation. 
  • Persistence of portosystemic collaterals and splenomegaly on CT after orthotopic liver transplantation. 
  • Phenotype and patterns of inflammatory cell infiltration associated with rejection or acceptance of rat liver allografts. 
  • Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation. 
  • Planned Initiation of Venoarterial Extracorporeal Membrane Oxygenation Prior to Liver Transplantation in a Patient With Severe Portopulmonary Hypertension. 
  • Planned right ventricular support for combined heart-liver transplantation. 
  • Plasma nitrite and nitrate levels as a noninvasive marker of pathology after human small bowel transplantation. 
  • Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation. 
  • Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. 
  • Porcine hepatic phospholipid efflux during reperfusion after cold ischemia. 
  • Portacaval shunts for ascites: another perspective. 
  • Portal Steal Syndrome After Full-Size Deceased Donor Liver Transplantation. 
  • Portal hypertension: from Eck's fistula to TIPS. 
  • Portal hypertension: surgical management in the 1990s. 
  • Portal venous gas after hepatic transplantation: sonographic detection and clinical significance. 
  • Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. 
  • Portopulmonary hypertension and the liver transplant candidate. 
  • Portosystemic shunts in children: a 15-year experience. 
  • Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C. 
  • Post-Reperfusion Syndrome in Liver Transplantation-An Overview. 
  • Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. 
  • Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. 
  • Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. 
  • Pre- and post-transplant bacterial infections in liver transplant recipients. 
  • Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. 
  • Preliminary experience with split liver transplantation. 
  • Preoperative Echocardiographic Differences and Transplant Outcomes Among Patients Receiving Simultaneous Liver-Kidney Versus Liver Transplant Alone. 
  • Preoperative delta-MELD score does not independently predict mortality after liver transplantation. 
  • Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio. 
  • Preoperative vascular imaging in pediatric liver transplantation. 
  • Pretransplant predictors of recovery of renal function after liver transplantation. 
  • Pretransplant status and patient survival following liver transplantation. 
  • Prevalence and Patterns of Opioid Use Before and After Liver Transplantation. 
  • Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group. 
  • Primary biliary cirrhosis: new therapeutic directions. 
  • Pro: low central venous pressure during liver transplantation--not too low. 
  • Proceed with caution: liver transplantation for metastatic neuroendocrine tumors. 
  • Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. 
  • Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. 
  • Prolonged survival of hepatic xenografts in the hamster to rat combination: efficacy of cyclosporine in combination with splenectomy. 
  • Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates. 
  • Protective effects of ischemic preconditioning on the cold-preserved liver are tyrosine kinase dependent. 
  • Protein kinase C inhibition abrogates hepatic ischemic preconditioning responses. 
  • Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly. 
  • Public perceptions of the importance of prognosis in allocating transplantable livers to children. 
  • Pulmonary infiltrates and eosinophilia in an FK 506 liver transplant recipient. 
  • Pure red cell aplasia following pegylated interferon alpha treatment. 
  • Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease. 
  • Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. 
  • Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. 
  • Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers. 
  • Randomized trial of an uncertainty self-management telephone intervention for patients awaiting liver transplant. 
  • Rates of employment after liver transplant: A nationwide cohort study. 
  • Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center. 
  • Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. 
  • Re: Distinguishing Between Sex and Gender Is Critical for Research in Transplantation. 
  • Real-world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high-risk donor seropositive/recipient seronegative (D+R-) liver transplant recipients (LTxR). 
  • Recipient Kupffer cell influx into xenografted liver. 
  • Recruitment of host progenitor cells in rat liver transplants. 
  • Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient. 
  • Regeneration of a transplanted liver after right hepatic lobectomy. 
  • Regional variability in symptom-based MELD exceptions: a response to organ shortage? 
  • Regulation of biliary secretion following liver transplantation. 
  • Rejection of the liver transplant. 
  • Relationship between provider volume and outcomes for orthotopic liver transplantation. 
  • Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. 
  • Renal Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US Multicenter Simultaneous Liver-Kidney Transplantation Consortium. 
  • Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. 
  • Reply. 
  • Reply: Is hepatocyte necrosis a good marker of donor liver viability during machine perfusion? 
  • Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. 
  • Rescue of a living donor with liver transplantation. 
  • Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. 
  • Response to the Comment on "Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis". 
  • Results of combined hepatic, pancreaticoduodenal, and renal procurements. 
  • Retransplantation of the liver--a seven-year experience. 
  • Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. 
  • Reversible cardiomyopathies--a review. 
  • Reversible retinal edema in an infant with neonatal hemochromatosis and liver failure. 
  • Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. 
  • Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. 
  • Risk versus reward: total joint arthroplasty outcomes after various solid organ transplantations. 
  • Role of coronary artery calcium score in identifying occult coronary artery disease in patients evaluated for deceased-donor liver transplant - a preliminary report. 
  • Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation. 
  • Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation. 
  • Safety and efficacy of living donor liver preservation with HTK solution. 
  • Seek and you will find: antibody and the liver. 
  • Selective bowel decontamination in hospitalized patients awaiting liver transplantation. 
  • Setting organ allocation priorities: should we care what the public cares about? 
  • Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors. 
  • Should abdominal cluster transplantation be abandoned? 
  • Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. 
  • Significant prolongation of hamster liver transplant survival in Lewis rats by total-lymphoid irradiation, cyclosporine, and splenectomy. 
  • Single-center experience of transplantation for polycystic liver disease. 
  • Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. 
  • Sirtuin-1 expression and activity is diminished in aged liver grafts. 
  • Society of pediatric liver transplantation: Current registry status 2011-2018. 
  • Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. 
  • Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. 
  • Solid organ transplantation in primary mitochondrial disease: Proceed with caution. 
  • Sonographic appearance of oxidized cellulose (Surgicel): pitfall in the diagnosis of postoperative abscess. 
  • Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry. 
  • Splenectomy is not indicated in living donor liver transplantation. 
  • State of the art of liver transplantation in the USA. 
  • Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients. 
  • Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes. 
  • Successful combined liver/kidney transplantation from a donor with Pompe disease. 
  • Successful emergency transplantation of a liver allograft from a donor maintained on extracorporeal membrane oxygenation. 
  • Successful extrarenal transplantation from non-heart-beating donors. 
  • Successful organ donation after long-term circulatory support with nonpulsatile mechanical support. 
  • Successful treatment of immune thrombocytopenic purpura with anti-D antibody following a cadaveric liver transplant for hepatoblastoma. 
  • Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. 
  • Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. 
  • Suprahepatic venacavaplasty (cavaplasty) with retrohepatic cava extension in liver transplantation: experience with first 115 cases. 
  • Surgical clearance for the patient with chronic liver disease. 
  • Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience. 
  • Surgical refinements in liver transplantation. 
  • Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. 
  • Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. 
  • Takotsubo cardiomyopathy and coronary vasospasm during orthotopic liver transplantation: separate entities or common mechanism? 
  • Takotsubo cardiomyopathy in a liver transplant recipient: a diagnosis of exclusion? 
  • Telemedicine in Hepatology: Current Applications and Future Directions. 
  • Temporal Trends and Evolving Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US SLKT Consortium. 
  • Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States. 
  • Textbook Outcomes in Liver Transplantation. 
  • Textbook Outcomes in Liver Transplantation. 
  • The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis. 
  • The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and Outcomes. 
  • The Organ Transplant Imperative. 
  • The clinical relevance of alloantibody in liver transplantation. 
  • The current status of living donor liver transplantation. 
  • The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat. 
  • The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. 
  • The efficacy and equity of retransplantation: an experimental survey of public attitudes. 
  • The evolution of a successful liver transplant program in 1996: the clinical and administrative role of the anesthesiologist. 
  • The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study. 
  • The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The impact of post-transplant diabetes mellitus on liver transplant outcomes. 
  • The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. 
  • The natural history of hepatitis C viral infection. 
  • The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature. 
  • The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. 
  • The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. 
  • The predictors of post-transplant coronary events among liver transplant recipients. 
  • The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. 
  • The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat. 
  • The role of class I antigens in hyperacute rejection of hepatic allografts in rats. 
  • The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. 
  • The role of donor-specific HLA alloantibodies in liver transplantation. 
  • The role of liver transplantation in the management of portal hypertension. 
  • The spectrum of ciclosporin nephrotoxicity. 
  • The use of UW solution in clinical transplantation. A 4-year experience. 
  • Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention. 
  • Therapy of acute and fulminant hepatitis B. 
  • Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. 
  • Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. 
  • Timing and Number of Cutaneous Squamous Cell Carcinomas in Transplant Recipients. 
  • Total blood transfusion and mortality after orthotopic liver transplantation. 
  • Toward Long-term Livers. 
  • Transjugular biopsy results in the transplanted liver: comparison of two surgical hepatic venous anastomotic configurations in 269 consecutive biopsies over a 14-year period. 
  • Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. 
  • Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. 
  • Transplantation for cholangiocarcinoma. 
  • Transplantation in alcoholics: separating prognosis and responsibility from social biases. 
  • Transplantation in the HIV+ patient. 
  • Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. 
  • Transplantation-mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors. 
  • Treatment of alcoholic liver disease. 
  • Treatment of multiple aneurysms of the splenic artery after liver transplantation by percutaneous embolization and laparoscopic splenectomy. 
  • Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. 
  • Two Cases and a Review of Graft-Versus-Host Disease and the Role of Hepatitis C Treatment in Liver Transplant Patients. 
  • Unique aspects of rejection and tolerance in liver transplantation. 
  • Update on Surgical Management of Small Bowel Neuroendocrine Tumors. 
  • Update on preservation of liver grafts. 
  • Use of OKT3 in kidney, pancreas, and liver transplantation. 
  • Use of Six-Minute Walk Test to Measure Functional Capacity After Liver Transplantation. 
  • Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease. 
  • Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension. 
  • Use of an inferior epigastic arterial catheter in a patient with difficult vascular access. 
  • Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. 
  • Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat. 
  • Vascular invasion is a prognostic indicator in hepatoblastoma. 
  • Venovenous bypass in adult orthotopic liver transplantation: routine or selective use? 
  • Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. 
  • Volume-mediated pulmonary responses in liver transplant candidates. 
  • What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society. 
  • What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model. 
  • What impact does a specialized center for transplantation and heptobiliary disease have on post-graduate resident training of gastroenterologists and surgeons? 
  • Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. 
  • Who should perform liver transplantation? Should that be the transplant surgeon, the hepatobilary surgeon, or the general surgeon? Part I: the transplant surgeon. 
  • Wilms Tumor After Orthotopic Liver Transplant in a Patient With Alagille Syndrome. 
  • Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma. 
• 

  Keywords of People

  • Amin, Mansi D, Assistant Professor of Pediatrics, Pediatrics, Gastroenterology, Hepatology and Nutrition
  • Eleswarpu, Sarada, Assistant Professor of Anesthesiology, Anesthesiology, General, Vascular, High Risk Transplant & Critical Care
  • Knechtle, Stuart Johnston, William R. Kenan, Jr. Distinguished Professor, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Muir, Andrew Joseph, Professor of Medicine, Duke Innovation & Entrepreneurship
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology